Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8195)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Nov 18, 2015 (publication date) through Dec 27, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Waisberg J, Saba GT. Wnt-/-β-catenin pathway signaling in human hepatocellular carcinoma. World J Hepatol 2015; 7(26): 2631-2635 [PMID: 26609340 DOI: 10.4254/wjh.v7.i26.2631] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v7/i26/2631.htm |
| Number | Citing Articles |
| 1 |
Ammad Farooqi, Chih-Wen Shu, Hurng-Wern Huang, Hui-Ru Wang, Yung-Ting Chang, Sundas Fayyaz, Shyng-Shiou Yuan, Jen-Yang Tang, Hsueh-Wei Chang. TRAIL, Wnt, Sonic Hedgehog, TGFβ, and miRNA Signalings Are Potential Targets for Oral Cancer Therapy. International Journal of Molecular Sciences 2017; 18(7): 1523 doi: 10.3390/ijms18071523
|
| 2 |
Hui Zhang, Yongyan Bi, Yuxi Wei, Jiayang Liu, Kudelaidi Kuerban, Li Ye. Blocking Wnt/β-catenin Signal Amplifies Anti-PD-1 Therapeutic Efficacy by Inhibiting Tumor Growth, Migration, and Promoting Immune Infiltration in Glioblastomas. Molecular Cancer Therapeutics 2021; 20(7): 1305 doi: 10.1158/1535-7163.MCT-20-0825
|
| 3 |
Guangyi Chen, Zhi-Ping Liu. Intelligent Computing Theories and Application. Lecture Notes in Computer Science 2021; 12838: 345 doi: 10.1007/978-3-030-84532-2_31
|
| 4 |
Abeer M. Ashmawy, Khaled M. Elgeshy, El-Said T. Abdel Salam, Mohamed Ghareeb, Mohamed H. Kobaisi, Hebat Allah A. Amin, Sabry K. Sharawy, Abdel Hady A. Abdel Wahab. Crosstalk between liver-related microRNAs and Wnt/β-catenin pathway in hepatocellular carcinoma patients. Arab Journal of Gastroenterology 2017; 18(3): 144 doi: 10.1016/j.ajg.2017.09.001
|
| 5 |
Yang Zhou, Xun Liu, Yahan Gao, Rulan Tan, Zhiyuan Wu, Qixin Zhong, Feng Zeng. Paeoniflorin Affects Hepatocellular Carcinoma Progression by Inhibiting Wnt/β-Catenin Pathway through Downregulation of 5-HT1D. Current Pharmaceutical Biotechnology 2021; 22(9): 1246 doi: 10.2174/1389201021666201009153808
|
| 6 |
Jian Li, Hui Zhang, Songhua Bei, Xiaohong Zhang, Huanqing Li, Li Ye, Li Feng. Disruption of Wnt/β-catenin Pathway Elevates the Sensitivity of Gastric Cancer Cells to PD-1 Antibody. Current Molecular Pharmacology 2022; 15(3): 557 doi: 10.2174/1874467214666210617163821
|
| 7 |
Kiyoyuki Minamiguchi, Mariko Irizato, Tomoko Uchiyama, Ryosuke Taiji, Hideyuki Nishiofuku, Nagaaki Marugami, Toshihiro Tanaka. Hepatobiliary-phase gadolinium ethoxybenzyl-diethylenetriaminepentaacetic acid MRI for pretreatment prediction of efficacy-to-standard-therapies based on Barcelona Clinic Liver Cancer algorithm: an up-to-date review. European Radiology 2023; 33(12): 8764 doi: 10.1007/s00330-023-09950-0
|
| 8 |
Weicheng Liang, Chuanjian Shi, Weilong Hong, Panlong Li, Xue Zhou, Weiming Fu, Lizhu Lin, Jinfang Zhang. Super-enhancer-driven lncRNA-DAW promotes liver cancer cell proliferation through activation of Wnt/β-catenin pathway. Molecular Therapy - Nucleic Acids 2021; 26: 1351 doi: 10.1016/j.omtn.2021.10.028
|
| 9 |
Nourhan Badwei. Hepatocellular Carcinoma Gene Expression: The New Era, Where It goes?. iLIVER 2023; 2(1): 36 doi: 10.1016/j.iliver.2022.12.001
|
| 10 |
Faten Farouk, Ibrahim M. Ibrahim, Salma Sherif, Heba Gamal Abdelhamed, Marwa Sharaky, Ahmed A. Al‐Karmalawy. Investigating the effect of polymerase inhibitors on cellular proliferation: Computational studies, cytotoxicity, CDK1 inhibitory potential, and LC‐MS/MS cancer cell entrapment assays. Chemical Biology & Drug Design 2024; 103(3) doi: 10.1111/cbdd.14500
|
| 11 |
Younglan Lim, Nam-On Ku. Revealing the Roles of Keratin 8/18-Associated Signaling Proteins Involved in the Development of Hepatocellular Carcinoma. International Journal of Molecular Sciences 2021; 22(12): 6401 doi: 10.3390/ijms22126401
|
| 12 |
Yagmur Azbazdar, Yeliz Demirci, Guillaume Heger, Dogac Ipekgil, Mustafa Karabicici, Gunes Ozhan. Comparative membrane lipidomics of hepatocellular carcinoma cells reveals diacylglycerol and ceramide as key regulators of Wnt/β‐catenin signaling and tumor growth. Molecular Oncology 2023; 17(11): 2314 doi: 10.1002/1878-0261.13520
|
| 13 |
A.M. Khalaf, D. Fuentes, A. Morshid, A.O. Kaseb, M. Hassan, J.D. Hazle, K.M. Elsayes. Hepatocellular carcinoma response to transcatheter arterial chemoembolisation using automatically generated pre-therapeutic tumour volumes by a random forest-based segmentation protocol. Clinical Radiology 2019; 74(12): 974.e13 doi: 10.1016/j.crad.2019.07.023
|
| 14 |
Ning Zhang, Hui Li, Chengdong Qin, Dening Ma, Yiming Zhao, Weiping Zhu, Lu Wang. Insufficient radiofrequency ablation promotes the metastasis of residual hepatocellular carcinoma cells via upregulating flotillin proteins. Journal of Cancer Research and Clinical Oncology 2019; 145(4): 895 doi: 10.1007/s00432-019-02852-z
|
| 15 |
Guangyi Chen, Zhi-Ping Liu. Inferring causal gene regulatory network via GreyNet: From dynamic grey association to causation. Frontiers in Bioengineering and Biotechnology 2022; 10 doi: 10.3389/fbioe.2022.954610
|
| 16 |
Fabio Gionfra, Paolo De Vito, Valentina Pallottini, Hung-Yun Lin, Paul J. Davis, Jens Z. Pedersen, Sandra Incerpi. The Role of Thyroid Hormones in Hepatocyte Proliferation and Liver Cancer. Frontiers in Endocrinology 2019; 10 doi: 10.3389/fendo.2019.00532
|
| 17 |
Pia Kronschnabl, Arnold Gr�nweller, Roland Hartmann, Achim Aigner, Ulrike Weirauch. Inhibition of PIM2 in liver cancer decreases tumor cell proliferation in�vitro and in�vivo primarily through the modulation of cell cycle progression. International Journal of Oncology 2019; doi: 10.3892/ijo.2019.4936
|
| 18 |
Rebecca Allen, Daneng Li. Oncology in the Precision Medicine Era. 2020; : 259 doi: 10.1007/978-3-030-31471-2_16
|
| 19 |
S Mahmoud A Najafi. The Canonical Wnt Signaling (Wnt/β-Catenin Pathway): A Potential Target for Cancer Prevention and Therapy. Iranian Biomedical Journal 2020; 24(5): 264 doi: 10.29252/ibj.24.5.264
|
| 20 |
P. Manka, J.D. Coombes, R. Boosman, K. Gauthier, S. Papa, W.K. Syn. Thyroid hormone in the regulation of hepatocellular carcinoma and its microenvironment. Cancer Letters 2018; 419: 175 doi: 10.1016/j.canlet.2018.01.055
|
| 21 |
Xiaoling Luo, Yuting Liu, Shijie Ma, Lei Liu, Rui Xie, Shaochuang Wang. WDR34 Activates Wnt/Beta-Catenin Signaling in Hepatocellular Carcinoma. Digestive Diseases and Sciences 2019; 64(9): 2591 doi: 10.1007/s10620-019-05583-w
|
| 22 |
Ali Morshid, Khaled M. Elsayes, Ahmed M. Khalaf, Mohab M. Elmohr, Justin Yu, Ahmed O. Kaseb, Manal Hassan, Armeen Mahvash, Zhihui Wang, John D. Hazle, David Fuentes. A Machine Learning Model to Predict Hepatocellular Carcinoma Response to Transcatheter Arterial Chemoembolization. Radiology: Artificial Intelligence 2019; 1(5): e180021 doi: 10.1148/ryai.2019180021
|
| 23 |
Filip Ambrozkiewicz, Andriy Trailin, Lenka Červenková, Radka Vaclavikova, Vojtech Hanicinec, Mohammad Al Obeed Allah, Richard Palek, Vladislav Třeška, Ondrej Daum, Zbyněk Tonar, Václav Liška, Kari Hemminki. CTNNB1 mutations, TERT polymorphism and CD8+ cell densities in resected hepatocellular carcinoma are associated with longer time to recurrence. BMC Cancer 2022; 22(1) doi: 10.1186/s12885-022-09989-0
|
| 24 |
Yangtao Xue, Yeling Ruan, Yali Wang, Peng Xiao, Junjie Xu. Signaling pathways in liver cancer: pathogenesis and targeted therapy. Molecular Biomedicine 2024; 5(1) doi: 10.1186/s43556-024-00184-0
|
| 25 |
Kurt Sartorius, Julia Makarova, Benn Sartorius, Ping An, Cheryl Winkler, Anil Chuturgoon, Anna Kramvis. The Regulatory Role of MicroRNA in Hepatitis-B Virus-Associated Hepatocellular Carcinoma (HBV-HCC) Pathogenesis. Cells 2019; 8(12): 1504 doi: 10.3390/cells8121504
|
| 26 |
Zekun Zhao, Tenglu Cui, Fengxian Wei, Zhiming Zhou, Yuan Sun, Chaofeng Gao, Xiaodong Xu, Huihan Zhang. Wnt/β-Catenin signaling pathway in hepatocellular carcinoma: pathogenic role and therapeutic target. Frontiers in Oncology 2024; 14 doi: 10.3389/fonc.2024.1367364
|
| 27 |
Katarzyna Kempinska, Bhavna Malik, Dmitry Borkin, Szymon Klossowski, Shirish Shukla, Hongzhi Miao, Jingya Wang, Tomasz Cierpicki, Jolanta Grembecka. Pharmacologic Inhibition of the Menin–MLL Interaction Leads to Transcriptional Repression of PEG10 and Blocks Hepatocellular Carcinoma. Molecular Cancer Therapeutics 2018; 17(1): 26 doi: 10.1158/1535-7163.MCT-17-0580
|
| 28 |
Maria J. Perugorria, Paula Olaizola, Ibone Labiano, Aitor Esparza-Baquer, Marco Marzioni, Jose J. G. Marin, Luis Bujanda, Jesus M. Banales. Wnt–β-catenin signalling in liver development, health and disease. Nature Reviews Gastroenterology & Hepatology 2019; 16(2): 121 doi: 10.1038/s41575-018-0075-9
|
| 29 |
Xiaoling Luo, Yuting Liu, Shijie Ma, Lei Liu, Rui Xie, Miaomiao Li, Peng Shen, Shaochuang Wang. STIP1 is over-expressed in hepatocellular carcinoma and promotes the growth and migration of cancer cells. Gene 2018; 662: 110 doi: 10.1016/j.gene.2018.03.076
|
| 30 |
Renumathy Dhanasekaran, Hiroyuki Suzuki, Lea Lemaitre, Naoto Kubota, Yujin Hoshida. Molecular and immune landscape of hepatocellular carcinoma to guide therapeutic decision-making. Hepatology 2023; doi: 10.1097/HEP.0000000000000513
|
| 31 |
Yagmur Azbazdar, Nydia Tejeda-Munoz, Julia C. Monka, Alex Dayrit, Grace Binder, Gunes Ozhan, Edward M. De Robertis. Addition of exogenous diacylglycerol enhances Wnt/β-catenin signaling through stimulation of macropinocytosis. iScience 2023; 26(10): 108075 doi: 10.1016/j.isci.2023.108075
|
| 32 |
Asmaa G. Abdou, Nanis S. Holah, Dina S. Elazab, Walaa G. El-Gendy, Mohammed T. Badr, Dalia R. Al-Sharaky. Hepatocellular Carcinoma Score and Subclassification Into Aggressive Subtypes Using Immunohistochemical Expression of p53, β-Catenin, CD133, and Ki-67. Applied Immunohistochemistry & Molecular Morphology 2021; 29(1): 20 doi: 10.1097/PAI.0000000000000840
|
| 33 |
Nia Adeniji, Renumathy Dhanasekaran. Genomic Landscape of HCC. Current Hepatology Reports 2020; 19(4): 448 doi: 10.1007/s11901-020-00553-7
|
| 34 |
Mercedes Arnés, Sergio Casas Tintó. Aberrant Wnt signaling: a special focus in CNS diseases. Journal of Neurogenetics 2017; 31(4): 216 doi: 10.1080/01677063.2017.1338696
|
| 35 |
Chong Lei, Qiujie Wang, Ni Tang, Kai Wang. GSTZ1‐1 downregulates Wnt/β‐catenin signalling in hepatocellular carcinoma cells. FEBS Open Bio 2020; 10(1): 6 doi: 10.1002/2211-5463.12769
|
| 36 |
Zhong-Liang Su, Chien-Wei Su, Yi-Luen Huang, Wan-Yu Yang, Bonifasius Putera Sampurna, Toru Ouchi, Kuan-Lin Lee, Chen-Sheng Wu, Horng-Dar Wang, Chiou-Hwa Yuh. A Novel AURKA Mutant-Induced Early-Onset Severe Hepatocarcinogenesis Greater than Wild-Type via Activating Different Pathways in Zebrafish. Cancers 2019; 11(7): 927 doi: 10.3390/cancers11070927
|
| 37 |
Maha Fezza, Mayssam Moussa, Rita Aoun, Rita Haber, George Hilal, Masaru Katoh. DKK1 promotes hepatocellular carcinoma inflammation, migration and invasion: Implication of TGF-β1. PLOS ONE 2019; 14(9): e0223252 doi: 10.1371/journal.pone.0223252
|
| 38 |
Tennyson Prakash Rayginia, Chenicheri Kizhakkeveettil Keerthana, Sadiq Chembothumparambil Shifana, Maria Joy Pellissery, Ajmani Abhishek, Ruby John Anto. Phytochemicals as Potential Lead Molecules against Hepatocellular
Carcinoma. Current Medicinal Chemistry 2024; 31(32): 5199 doi: 10.2174/0109298673275501231213063902
|
| 39 |
Chaoxing Li, Valentin Dinu. miR2Pathway: A novel analytical method to discover MicroRNA-mediated dysregulated pathways involved in hepatocellular carcinoma. Journal of Biomedical Informatics 2018; 81: 31 doi: 10.1016/j.jbi.2018.03.013
|
| 40 |
J. Regneri, B. Klotz, M. Schartl. Genetics, Genomics and Fish Phenomics. Advances in Genetics 2016; 95: 31 doi: 10.1016/bs.adgen.2016.04.001
|